Market open
Sionna Therapeutics, Inc./$SION
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sionna Therapeutics, Inc.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Ticker
$SION
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
41
Website
SION Metrics
BasicAdvanced
$512M
-
-$15.99
-
-
Price and volume
Market cap
$512M
52-week high
$17.81
52-week low
$9.37
Financial strength
Current ratio
14.491
Quick ratio
14.159
Long term debt to equity
5.207
Total debt to equity
5.85
Management effectiveness
Return on assets (TTM)
-37.10%
Return on equity (TTM)
-61.44%
Valuation
Price to book
-0.33
Price to tangible book (TTM)
-0.33
Price to free cash flow (TTM)
-0.848
Growth
Earnings per share change (TTM)
-0.79%
SION News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Sionna Therapeutics, Inc. stock?
Sionna Therapeutics, Inc. (SION) has a market cap of $512M as of April 04, 2025.
What is the P/E ratio for Sionna Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Sionna Therapeutics, Inc. (SION) stock is 0 as of April 04, 2025.
Does Sionna Therapeutics, Inc. stock pay dividends?
No, Sionna Therapeutics, Inc. (SION) stock does not pay dividends to its shareholders as of April 04, 2025.
When is the next Sionna Therapeutics, Inc. dividend payment date?
Sionna Therapeutics, Inc. (SION) stock does not pay dividends to its shareholders.
What is the beta indicator for Sionna Therapeutics, Inc.?
Sionna Therapeutics, Inc. (SION) does not currently have a Beta indicator.